Latest Health News
Aid Cuts Could Lead to 9.4 Million Preventable Deaths
Experts warn that reductions in global health aid could result in 9.4 million preventable deaths, emphasizing the urgency due to immediate impacts on human lives. The analysis highlights that any claim of implementing cuts without high human cost is unfounded.
This comes amid fragile global health funding.
Cholera Vaccine Shortage Ends with 20 Million Doses Distributed
The WHO announced the end of the cholera vaccine shortage, with global supply doubled since 2022, enabling pre-emptive vaccinations. Doses are being allocated to Mozambique, Bangladesh, and the Democratic Republic of the Congo to restart campaigns.
This addresses a resurgence fueled by prior supply issues in Africa.
WHO Secures 85% of Core Budget but Faces Shortfalls
The WHO has mobilized 85% of resources for its core budget, averting a deeper crisis through increased mandatory contributions. However, the remaining 15% for emergency preparedness, antimicrobial resistance, and climate resilience remains challenging to secure.
Director-General Tedros noted this partial stabilization in global health funding.
Democratic States Sue Trump Admin Over $600M Health Cuts
Four Democratic-led states—California, Colorado, Illinois, and Minnesota—sued the Trump administration to block $600 million in public health grant cuts. The cuts are alleged to be retaliation for opposition to immigration policies.
This impacts essential public health funding amid political tensions.
WHO Appeals for $38.8M to Aid 10.5M in Yemen
The WHO is seeking $38.8 million for emergency health assistance to 10.5 million Yemenis in 2026 amid conflict and outbreaks. Challenges include cholera, measles, dengue, polio, and malnutrition, with only 60% of facilities functional.
Funding delays risk unchecked disease spread and service reductions.
New Mouse Model Reveals Skin's Role in Lupus Progression
A novel keratinocyte-driven mouse model mimics human lupus, showing skin defects can trigger systemic autoimmune responses. It features reversible symptoms for studying onset, remission, and relapse, aiding drug testing.
This positions skin as a potential initiator, opening new therapeutic avenues.
Major Depressive Disorder Linked to Th2 Immune Pathway
Study identifies shared immune abnormalities between major depressive disorder and inflammatory skin diseases via the Th2 axis. Targeting IL-4 receptor alpha with dupilumab shows promise, with a clinical trial planned.
This suggests immunomodulatory treatments as a new depression therapy approach.
Seventh Human Case of H10N3 Bird Flu Detected
China reports the seventh human infection with H10N3 avian influenza, but public health risk remains low per WHO and CHP. No evidence of sustained human-to-human transmission.
Ongoing monitoring is advised for potential zoonotic threats.
US Joins WHO Flu Vaccine Meeting Despite Withdrawal
The US will participate in WHO's February 26 meeting on 2026-2027 influenza vaccine composition, despite prior withdrawal. This involves northern hemisphere strains discussion.
It signals continued collaboration on vaccine development.
Poll Shows Declining Perceived Safety of Key Vaccines
An Annenberg poll indicates a drop in US adults' perceived safety of flu, COVID-19, and MMR vaccines over three years. Though most still view them as safe, the decline raises vaccine hesitancy concerns.
This trend warrants public health communication efforts.
Advocacy Groups Urge Merck for Global HIV Prevention Pill Access
Over 170 groups from 30 countries call on Merck to ensure wide access to its investigational HIV prevention pill. Still in trials, a global strategy is urged preemptively.
This aims to prevent access barriers post-approval.
SickKids Scientists Advance Child Health Research
Seven SickKids researchers lead breakthroughs in glioma, neuroblastoma, and biomolecular condensates for child conditions. Recent publications cover molecular landscapes and therapeutic potentials in pediatric cancers.
Their work shapes future treatments for neurodegenerative and oncologic diseases.